The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 02, 2024

Filed:

Jan. 23, 2023
Applicant:

Fenwal, Inc., Lake Zurich, IL (US);

Inventors:

Zahra R Ali, Chicago, IL (US);

Lan T. Nguyen, Vernon Hills, IL (US);

Assignee:

Fenwal, Inc., Lake Zurich, IL (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61M 1/36 (2006.01); A61M 1/38 (2006.01); A61M 1/02 (2006.01);
U.S. Cl.
CPC ...
A61M 1/3607 (2014.02); A61M 1/0209 (2013.01); A61M 1/361 (2014.02); A61M 1/3643 (2013.01); A61M 1/3672 (2013.01); A61M 1/3683 (2014.02); A61M 1/3693 (2013.01); A61M 1/3696 (2014.02); A61M 1/38 (2013.01); A61M 2202/0092 (2013.01); A61M 2202/0407 (2013.01); A61M 2202/0413 (2013.01); A61M 2202/0415 (2013.01); A61M 2202/0429 (2013.01); A61M 2202/0439 (2013.01); A61M 2202/0443 (2013.01); A61M 2205/3386 (2013.01); A61M 2205/50 (2013.01); A61M 2230/005 (2013.01); A61M 2230/207 (2013.01);
Abstract

Described is a method for controlling fluid volume balance. A controller is configured with a first set of inputs comprising a hematocrit, a total blood volume, and an ACD ratio. A maximum extracorporeal RBC amount during the procedure is estimated based on the first set of inputs. A fluid circuit is primed with a priming fluid. Whole blood is drawn from a blood source and separated into a RBC component, a target cell component, and a plasma component. The target cell component is directed to a product container. The product container comprising the target cell component is treated. A treated target cell component, a portion of the RBC component remaining in the fluid circuit, and/or a portion of the plasma component remaining in the fluid circuit are returned to the blood source. A first response action is provided if the maximum extracorporeal RBC amount estimated is above a programmed limit.


Find Patent Forward Citations

Loading…